tiprankstipranks
KalVista Pharmaceuticals (KALV)
NASDAQ:KALV

KalVista Pharmaceuticals (KALV) Similar Stocks

Compare
410 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
KalVista Pharmaceuticals
$11.89
$591.12M
6.83%
7 Buy
0 Hold
0 Sell
Strong Buy
BioCryst
$7.98
$1.67B
62.53%
10 Buy
1 Hold
0 Sell
Strong Buy
FibroGen
$0.32
$31.79M
-88.07%
1 Buy
1 Hold
0 Sell
Moderate Buy
AnaptysBio
$17.08
$523.79M
-21.18%
9 Buy
2 Hold
0 Sell
Strong Buy
Kiniksa Pharmaceuticals
$23.36
$1.70B
14.79%
5 Buy
0 Hold
0 Sell
Strong Buy
Arcutis Biotherapeutics
$17.01
$2.02B
77.00%
7 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
KALV
KalVista Pharmaceuticals
11.89
0.76
6.83%
BCRX
BioCryst
7.98
3.07
62.53%
FGEN
FibroGen
0.32
-2.32
-87.88%
ANAB
AnaptysBio
17.08
-4.02
-19.05%
KNSA
Kiniksa Pharmaceuticals
23.36
3.40
17.03%
ARQT
Arcutis Biotherapeutics
17.01
7.75
83.69%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis